Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries

Diana Aguiar de Sousa, Rascha von Martial, Sònia Abilleira, Thomas Gattringer, Adam Kobayashi, Miquel Gallofré, Franz Fazekas, I. Szikora, Valery Feigin, Valeria Caso, Urs Fischer

Research output: Article

4 Citations (Scopus)

Abstract

Introduction: Acute stroke unit care, intravenous thrombolysis and endovascular treatment significantly improve the outcome for patients with ischaemic stroke, but data on access and delivery throughout Europe are lacking. We assessed best available data on access and delivery of acute stroke unit care, intravenous thrombolysis and endovascular treatment throughout Europe. Methods: A survey, drafted by stroke professionals (ESO, ESMINT, EAN) and a patient organisation (SAFE), was sent to national stroke societies and experts in 51 European countries (World Health Organization definition) requesting experts to provide national data on stroke unit, intravenous thrombolysis and endovascular treatment rates. We compared both pooled and individual national data per one million inhabitants and per 1000 annual incident ischaemic strokes with highest country rates. Population estimates were based on United Nations data, stroke incidences on the Global Burden of Disease Report. Results: We obtained data from 44 European countries. The estimated mean number of stroke units was 2.9 per million inhabitants (95% CI 2.3–3.6) and 1.5 per 1000 annual incident strokes (95% CI 1.1–1.9), highest country rates were 9.2 and 5.8. Intravenous thrombolysis was provided in 42/44 countries. The estimated mean annual number of intravenous thrombolysis was 142.0 per million inhabitants (95% CI 107.4–176.7) and 72.7 per 1000 annual incident strokes (95% CI 54.2–91.2), highest country rates were 412.2 and 205.5. Endovascular treatment was provided in 40/44 countries. The estimated mean annual number of endovascular treatments was 37.1 per million inhabitants (95% CI 26.7–47.5) and 19.3 per 1000 annual incident strokes (95% CI 13.5–25.1), highest country rates were 111.5 and 55.9. Overall, 7.3% of incident ischaemic stroke patients received intravenous thrombolysis (95% CI 5.4–9.1) and 1.9% received endovascular treatment (95% CI 1.3–2.5), highest country rates were 20.6% and 5.6%. Conclusion: We observed major inequalities in acute stroke treatment between and within 44 European countries. Our data will assist decision makers implementing tailored stroke care programmes for reducing stroke-related morbidity and mortality in Europe.

Original languageEnglish
Pages (from-to)13-28
Number of pages16
JournalEuropean Stroke Journal
Volume4
Issue number1
DOIs
Publication statusPublished - márc. 1 2019

Fingerprint

Stroke
Therapeutics
Surveys and Questionnaires
United Nations
Organizations
Morbidity

Keywords

    ASJC Scopus subject areas

    • Clinical Neurology
    • Cardiology and Cardiovascular Medicine

    Cite this

    Aguiar de Sousa, D., von Martial, R., Abilleira, S., Gattringer, T., Kobayashi, A., Gallofré, M., ... Fischer, U. (2019). Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries. European Stroke Journal, 4(1), 13-28. https://doi.org/10.1177/2396987318786023

    Access to and delivery of acute ischaemic stroke treatments : A survey of national scientific societies and stroke experts in 44 European countries. / Aguiar de Sousa, Diana; von Martial, Rascha; Abilleira, Sònia; Gattringer, Thomas; Kobayashi, Adam; Gallofré, Miquel; Fazekas, Franz; Szikora, I.; Feigin, Valery; Caso, Valeria; Fischer, Urs.

    In: European Stroke Journal, Vol. 4, No. 1, 01.03.2019, p. 13-28.

    Research output: Article

    Aguiar de Sousa, D, von Martial, R, Abilleira, S, Gattringer, T, Kobayashi, A, Gallofré, M, Fazekas, F, Szikora, I, Feigin, V, Caso, V & Fischer, U 2019, 'Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries' European Stroke Journal, vol. 4, no. 1, pp. 13-28. https://doi.org/10.1177/2396987318786023
    Aguiar de Sousa, Diana ; von Martial, Rascha ; Abilleira, Sònia ; Gattringer, Thomas ; Kobayashi, Adam ; Gallofré, Miquel ; Fazekas, Franz ; Szikora, I. ; Feigin, Valery ; Caso, Valeria ; Fischer, Urs. / Access to and delivery of acute ischaemic stroke treatments : A survey of national scientific societies and stroke experts in 44 European countries. In: European Stroke Journal. 2019 ; Vol. 4, No. 1. pp. 13-28.
    @article{f4916eaffce44f00a66770b46d395367,
    title = "Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries",
    abstract = "Introduction: Acute stroke unit care, intravenous thrombolysis and endovascular treatment significantly improve the outcome for patients with ischaemic stroke, but data on access and delivery throughout Europe are lacking. We assessed best available data on access and delivery of acute stroke unit care, intravenous thrombolysis and endovascular treatment throughout Europe. Methods: A survey, drafted by stroke professionals (ESO, ESMINT, EAN) and a patient organisation (SAFE), was sent to national stroke societies and experts in 51 European countries (World Health Organization definition) requesting experts to provide national data on stroke unit, intravenous thrombolysis and endovascular treatment rates. We compared both pooled and individual national data per one million inhabitants and per 1000 annual incident ischaemic strokes with highest country rates. Population estimates were based on United Nations data, stroke incidences on the Global Burden of Disease Report. Results: We obtained data from 44 European countries. The estimated mean number of stroke units was 2.9 per million inhabitants (95{\%} CI 2.3–3.6) and 1.5 per 1000 annual incident strokes (95{\%} CI 1.1–1.9), highest country rates were 9.2 and 5.8. Intravenous thrombolysis was provided in 42/44 countries. The estimated mean annual number of intravenous thrombolysis was 142.0 per million inhabitants (95{\%} CI 107.4–176.7) and 72.7 per 1000 annual incident strokes (95{\%} CI 54.2–91.2), highest country rates were 412.2 and 205.5. Endovascular treatment was provided in 40/44 countries. The estimated mean annual number of endovascular treatments was 37.1 per million inhabitants (95{\%} CI 26.7–47.5) and 19.3 per 1000 annual incident strokes (95{\%} CI 13.5–25.1), highest country rates were 111.5 and 55.9. Overall, 7.3{\%} of incident ischaemic stroke patients received intravenous thrombolysis (95{\%} CI 5.4–9.1) and 1.9{\%} received endovascular treatment (95{\%} CI 1.3–2.5), highest country rates were 20.6{\%} and 5.6{\%}. Conclusion: We observed major inequalities in acute stroke treatment between and within 44 European countries. Our data will assist decision makers implementing tailored stroke care programmes for reducing stroke-related morbidity and mortality in Europe.",
    keywords = "acute stroke treatment, endovascular treatment, Europe, health care resources, intravenous thrombolysis, stroke unit, Survey",
    author = "{Aguiar de Sousa}, Diana and {von Martial}, Rascha and S{\`o}nia Abilleira and Thomas Gattringer and Adam Kobayashi and Miquel Gallofr{\'e} and Franz Fazekas and I. Szikora and Valery Feigin and Valeria Caso and Urs Fischer",
    year = "2019",
    month = "3",
    day = "1",
    doi = "10.1177/2396987318786023",
    language = "English",
    volume = "4",
    pages = "13--28",
    journal = "European Stroke Journal",
    issn = "2396-9873",
    publisher = "Sage Publications",
    number = "1",

    }

    TY - JOUR

    T1 - Access to and delivery of acute ischaemic stroke treatments

    T2 - A survey of national scientific societies and stroke experts in 44 European countries

    AU - Aguiar de Sousa, Diana

    AU - von Martial, Rascha

    AU - Abilleira, Sònia

    AU - Gattringer, Thomas

    AU - Kobayashi, Adam

    AU - Gallofré, Miquel

    AU - Fazekas, Franz

    AU - Szikora, I.

    AU - Feigin, Valery

    AU - Caso, Valeria

    AU - Fischer, Urs

    PY - 2019/3/1

    Y1 - 2019/3/1

    N2 - Introduction: Acute stroke unit care, intravenous thrombolysis and endovascular treatment significantly improve the outcome for patients with ischaemic stroke, but data on access and delivery throughout Europe are lacking. We assessed best available data on access and delivery of acute stroke unit care, intravenous thrombolysis and endovascular treatment throughout Europe. Methods: A survey, drafted by stroke professionals (ESO, ESMINT, EAN) and a patient organisation (SAFE), was sent to national stroke societies and experts in 51 European countries (World Health Organization definition) requesting experts to provide national data on stroke unit, intravenous thrombolysis and endovascular treatment rates. We compared both pooled and individual national data per one million inhabitants and per 1000 annual incident ischaemic strokes with highest country rates. Population estimates were based on United Nations data, stroke incidences on the Global Burden of Disease Report. Results: We obtained data from 44 European countries. The estimated mean number of stroke units was 2.9 per million inhabitants (95% CI 2.3–3.6) and 1.5 per 1000 annual incident strokes (95% CI 1.1–1.9), highest country rates were 9.2 and 5.8. Intravenous thrombolysis was provided in 42/44 countries. The estimated mean annual number of intravenous thrombolysis was 142.0 per million inhabitants (95% CI 107.4–176.7) and 72.7 per 1000 annual incident strokes (95% CI 54.2–91.2), highest country rates were 412.2 and 205.5. Endovascular treatment was provided in 40/44 countries. The estimated mean annual number of endovascular treatments was 37.1 per million inhabitants (95% CI 26.7–47.5) and 19.3 per 1000 annual incident strokes (95% CI 13.5–25.1), highest country rates were 111.5 and 55.9. Overall, 7.3% of incident ischaemic stroke patients received intravenous thrombolysis (95% CI 5.4–9.1) and 1.9% received endovascular treatment (95% CI 1.3–2.5), highest country rates were 20.6% and 5.6%. Conclusion: We observed major inequalities in acute stroke treatment between and within 44 European countries. Our data will assist decision makers implementing tailored stroke care programmes for reducing stroke-related morbidity and mortality in Europe.

    AB - Introduction: Acute stroke unit care, intravenous thrombolysis and endovascular treatment significantly improve the outcome for patients with ischaemic stroke, but data on access and delivery throughout Europe are lacking. We assessed best available data on access and delivery of acute stroke unit care, intravenous thrombolysis and endovascular treatment throughout Europe. Methods: A survey, drafted by stroke professionals (ESO, ESMINT, EAN) and a patient organisation (SAFE), was sent to national stroke societies and experts in 51 European countries (World Health Organization definition) requesting experts to provide national data on stroke unit, intravenous thrombolysis and endovascular treatment rates. We compared both pooled and individual national data per one million inhabitants and per 1000 annual incident ischaemic strokes with highest country rates. Population estimates were based on United Nations data, stroke incidences on the Global Burden of Disease Report. Results: We obtained data from 44 European countries. The estimated mean number of stroke units was 2.9 per million inhabitants (95% CI 2.3–3.6) and 1.5 per 1000 annual incident strokes (95% CI 1.1–1.9), highest country rates were 9.2 and 5.8. Intravenous thrombolysis was provided in 42/44 countries. The estimated mean annual number of intravenous thrombolysis was 142.0 per million inhabitants (95% CI 107.4–176.7) and 72.7 per 1000 annual incident strokes (95% CI 54.2–91.2), highest country rates were 412.2 and 205.5. Endovascular treatment was provided in 40/44 countries. The estimated mean annual number of endovascular treatments was 37.1 per million inhabitants (95% CI 26.7–47.5) and 19.3 per 1000 annual incident strokes (95% CI 13.5–25.1), highest country rates were 111.5 and 55.9. Overall, 7.3% of incident ischaemic stroke patients received intravenous thrombolysis (95% CI 5.4–9.1) and 1.9% received endovascular treatment (95% CI 1.3–2.5), highest country rates were 20.6% and 5.6%. Conclusion: We observed major inequalities in acute stroke treatment between and within 44 European countries. Our data will assist decision makers implementing tailored stroke care programmes for reducing stroke-related morbidity and mortality in Europe.

    KW - acute stroke treatment

    KW - endovascular treatment

    KW - Europe

    KW - health care resources

    KW - intravenous thrombolysis

    KW - stroke unit

    KW - Survey

    UR - http://www.scopus.com/inward/record.url?scp=85060508344&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85060508344&partnerID=8YFLogxK

    U2 - 10.1177/2396987318786023

    DO - 10.1177/2396987318786023

    M3 - Article

    VL - 4

    SP - 13

    EP - 28

    JO - European Stroke Journal

    JF - European Stroke Journal

    SN - 2396-9873

    IS - 1

    ER -